Resistance to Acute Nephrotoxicity Induced by Cadmium‐Metallothionein Dependence on Pretreatment with Cadmium Chloride

Publisher Website
Google Scholar
Abstract
Three groups of rats (B‐D) were given various daily doses of CdCl2(0.5–2 mg Cd/kg) continously or in intervals during time periods of 1–8 weeks. Another group of animals (A) were kept untreated. At the end of the period, selected subgroups of groups A‐D were given a single subcutaneous injection of109Cd‐metallothionein (109CdMT) 0.05 or 0.4 mg Cd/kg (“challenge dose”). Subsequently, urinary creatinine, protein, Cd,109Cd and MT and kidney cortex Cd,109Cd and MT were determined. In group A (no long term pretreatment), an increased proteinuria was observed after the rats had received the lower of the challenge doses of109CdMT, and an even greater increase after the higher challenge dose of109CdMT. No such increase appeared in group B, C and D (repeatedly pretreated with CdCl2) at either of the challenge doses. Higher metallothionein concentrations in kidney cortex observed in the pretreated groups constitute a plausible explanation of the protective effects of pretreatment against the development of increased proteinuria after challenge dosing. It is likely that increasing Cd concentrations, gradually accumulating in the renal cortex (22–226 μg/g wet wt.) as a result of the pretreatment, served to induce the synthesis of metallothionein in the renal cortical cells, thus making them resistant to the challenge from109CdMT.